Kejun (Albert) Ying is a PhD candidate at Harvard Medical School, specialising in ageing, metabolism, and genetics at the Gladyshev Lab. A recipient of the NIH F99/K00 award, he is deeply engaged in pioneering research on aging biomarkers and multi-omics approaches to understand genetic and epigenetic influences on healthspan. Kejun is also instrumental in initiatives like the Biomarkers of Aging Conference, which connects global scientists in the field. His recent work includes MethylGPT, a transformative model for DNA methylome analysis, enhancing predictive accuracy for age and disease risk. Kejun’s contributions reflect his commitment to advancing longevity research.